Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 3
2007 3
2008 3
2009 1
2010 1
2011 2
2012 6
2013 7
2014 12
2015 4
2016 5
2017 6
2018 6
2019 4
2020 9
2021 9
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
EMAS position statement: Thyroid disease and menopause.
Mintziori G, Veneti S, Poppe K, Goulis DG, Armeni E, Erel CT, Fistonić I, Hillard T, Hirschberg AL, Meczekalski B, Mendoza N, Mueck AO, Simoncini T, Stute P, van Dijken D, Rees M, Duntas L, Lambrinoudaki I. Mintziori G, et al. Among authors: mendoza n. Maturitas. 2024 Apr 24;185:107991. doi: 10.1016/j.maturitas.2024.107991. Online ahead of print. Maturitas. 2024. PMID: 38658290
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM; HMT Eligibility Criteria Group. Coronado PJ, et al. Among authors: mendoza n. Menopause. 2024 Mar 1;31(3):234-242. doi: 10.1097/GME.0000000000002317. Menopause. 2024. PMID: 38385734
EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA, Pofi R, Goulis DG, Isidori AM, Armeni E, Erel CT, Fistonić I, Hillard T, Hirschberg AL, Meczekalski B, Mendoza N, Mueck AO, Simoncini T, Stute P, van Dijken D, Rees M, Lambrinoudaki I. Kanakis GA, et al. Among authors: mendoza n. Maturitas. 2023 Dec;178:107854. doi: 10.1016/j.maturitas.2023.107854. Epub 2023 Oct 15. Maturitas. 2023. PMID: 37845136
Mediterranean diet for cancer prevention and survivorship.
Monllor-Tormos A, García-Vigara A, Morgan O, García-Pérez MÁ, Mendoza N, Tarín JJ, Cano A. Monllor-Tormos A, et al. Among authors: mendoza n. Maturitas. 2023 Dec;178:107841. doi: 10.1016/j.maturitas.2023.107841. Epub 2023 Aug 24. Maturitas. 2023. PMID: 37660598 Free article. Review.
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
Fiol G, Lete I, Nieto L, Santaballa A, Pla MJ, Baquedano L, Calaf J, Coronado P, de la Viuda E, Llaneza P, Otero B, Sánchez-Méndez S, Ramírez I, Mendoza N; “HMT Elegibility Criteria Group”. Fiol G, et al. Among authors: mendoza n. J Clin Med. 2023 Aug 12;12(16):5263. doi: 10.3390/jcm12165263. J Clin Med. 2023. PMID: 37629305 Free PMC article. Review.
EMAS position statement: Vitamin D and menopausal health.
Anagnostis P, Livadas S, Goulis DG, Bretz S, Ceausu I, Durmusoglu F, Erkkola R, Fistonic I, Gambacciani M, Geukes M, Hamoda H, Hartley C, Hirschberg AL, Meczekalski B, Mendoza N, Mueck A, Smetnik A, Stute P, van Trotsenburg M, Rees M, Lambrinoudaki I. Anagnostis P, et al. Among authors: mendoza n. Maturitas. 2023 Mar;169:2-9. doi: 10.1016/j.maturitas.2022.12.006. Epub 2022 Dec 21. Maturitas. 2023. PMID: 36566517 Review.
84 results